Stockhead’s Q-Wrapz video series features one-on-one interviews showcasing the latest quarterly results of emerging ASX companies.

In this instalment, former CNBC, Sky News, and Bloomberg news anchor Oriel Morrison interviews Roger Aston, executive chairman of PharmAust Ltd (ASX:PAA).

PharmAust is a listed clinical-stage company developing targeted cancer therapeutics to address both human and animal healthcare.

The company made headlines in July following news of it filing a patent for its lead drug monepantel for antiviral diseases.

To hear about the company’s quarterly highlights, standout areas and forward plan, click above.